Intestinal α-glucosidase and some pancreatic enzymes inhibitory effect of hydroalcholic extract of Moringa stenopetala leaves

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Toma, Alemayehu ^a,b   Makonnen, Eyasu ^a   Mekonnen, Yelamtsehay ^c   Debella, Asfaw ^d   Addisakwattana, Sirichai ^e  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b HAWASSA UNIVERSITY   (Ethiopia)

^c ADDIS ABABA UNIVERSITY   (Ethiopia)

^d ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^e CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Moringa stenopetala; Pancreatic enzymes; Phytochemical analysis; glucosidase

Indexed keywords

ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; AMYLASE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CATECHIN; CHOLESTEROL ESTERASE; FLAVONOID; GALLIC ACID; GLUCOSE OXIDASE; HERBACEOUS AGENT; MORINGA STENOPETALA EXTRACT; PHENOL DERIVATIVE; PLANT EXTRACT; QUERCETIN; SUCRASE; TANNIN DERIVATIVE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; ARTICLE; DRUG DETERMINATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GLYCEMIC CONTROL; IC 50; MEDICINAL PLANT; MORINGA; MORINGA STENOPETALA; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF;

ALPHA-GLUCOSIDASES; ANIMALS; DIABETES MELLITUS; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; HYDROLASES; HYPOGLYCEMIC AGENTS; INTESTINES; LIPASE; MORINGA; PANCREAS; PANCREATIC ALPHA-AMYLASES; PHENOLS; PLANT EXTRACTS; PLANT LEAVES; RATS; STEROL ESTERASE; SWINE;

EID: 84904171271     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-180     Document Type: Article

References (24)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care 2004, 27:1047-1053. 10.2337/diacare.27.5.1047, 15111519.
2. International Diabetes Federation Atlas 2013, 6, http://www.idf.org/diabetesatlas/downloaded in 30/11/2013.
3. Levin M, Pfeifer M. Uncomplicated Guide to Diabetes Complications 2009, Alexandria, Virginia: American Diabetes Association, 3.
4. Edwards S, Tadesse M, Demissew S, Hedberg J. Flora of Ethiopia and Eritrea: mangnoliaceae to flacourtiacea, the national herbarium. Ethiopia 2002, 1:155-163.
5. Mekonnen Y, Gessesse A. Documentation on the use of Moringa Stenopetala and its possible antileshimanial and antifertility effects. SINET: Ethiopian J Sci 1998, 21:287-295.
6. Mengistu M, Abebe Y, Mekonnen Y, Tolessa T. Invivo and invitro hypotensive effect of aqueous extract of Moringa stenopetala leaves. Afr Health Sci 2012, 12(4):445-451.
7. Mekonnen Y, Yardely V, Rock P, Croft S. In vitro antitrypanosomal activity of Moringa Stenopetala leaves and roots. Phytother Res 1999, 13:538-539. 10.1002/(SICI)1099-1573(199909)13:6<538::AID-PTR486>3.0.CO;2-K, 10479771.
8. Mekonnen Y. Effects of ethanol extracts of Moringa Stenopetala leave on guinea pig and mouse smooth muscle. Phytother Res 1999, 13:442-444. 10.1002/(SICI)1099-1573(199908/09)13:5<442::AID-PTR476>3.0.CO;2-7, 10441791.
9. Makonnen E, Hunde A, Damecha G. Hypoglycemic effect of Moringa Stenopetala aqueous extracts in Rabbits. Phytother Res 1997, 11:147-148.
10. Mussa A, Makonnen E, Urga K. Effects of the crude aqueous extract and isolated fraction of moringa stenopetala leaves in normal and diabetic mice. Pharmacologyonline 2008, 3:1049-1055.
11. Nardos A, Makonnen E, Debella A. Effects of crude extracts and fractions of Moringa stenopetala (Baker f) Cufodontis leaves in normoglycemic and alloxan-induced diabetic mice. Afr J Pharm Pharmacol 2011, 5:2220-2225.
12. Toma A, Makonnen E, Debella A, Tesfaye B. Antihyperglycemic effect on chronic administration of butanol fraction of ethanol extract of moringa stenopetala leaves in alloxan induced diabetic mice. Asian Pac J Trop Biomed 2012, 2:S1606-S1610.
13. Adisakwattana S, Chanathong B. α-glucosidase inhibitory activity and lipid-lowering mechanisms of Moringa oleifera leaf extract. Eur Rev Med Pharmacol Sci 2011, 15:803-808.
14. Mishra J, Yousuf A, Singh D, Aradhana A. Phytochemical investigation and in-vitro antioxidant potential of leaves of Murraya koengii. Int J Integr Biol 2009, 7:171-174.
15. Adisakwattana S, Ruengsamran T, Kampa P, Sompong W. Invitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase. BMC Complement Altern Med 2012, 12:110. 10.1186/1472-6882-12-110, 3522002, 22849553.
16. Lewis D, Liu D. Direct measurement of lipase inhibition by orlistat using dissolution linked in vitro assay. Clinic Pharmacol Biopharm 2012, 1:103. doi:10.4172/2167-065X.1000103.
17. Upendra M, Sreenivasulu M, Chengaiah B. Micro-vascular and macro-vascular complication of diabetes mellitus. IJPRIF 2010, 2:1883-1892.
18. Toma A. Recent advances on novel dual-acting peroxisome proliferator-activated receptor alpha and gamma agonists. Int J Pharm Sci Res 2013, 4:1644-1653.
19. Mukherjee P, Maiti K, Mukherjee K, Houghton P. Leads from Indian medicinal plants with hypoglycemic potentials. J Ethnopharmacol 2006, 106:1-28. 10.1016/j.jep.2006.03.021, 16678368.
20. Kurihara H, Ando J, Hatano M, Kawabata J. Sulfoquinovosyldacylglycerolas alpha glucosidase inhibitor. Bioorg Med chemlett 2011, 5:1241-1244.
21. Sama K, Murugesan K, Sivaraj R. Invitro alpha amylase and alpha glucosidase inhibition activity of crude ethanol extract of Cissus arnottiana. Asian J Plant Sci Res 2012, 4:550-553.
22. Jacobson T, Miller M, Schaefer E. Hypertriglyceridemia and cardiovascular risk reduction. Clin Ther 2007, 29:763-777. 10.1016/j.clinthera.2007.05.002, 17697898.
23. Birari R, Bhutani K. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today 2007, 12:879-889. 10.1016/j.drudis.2007.07.024, 17933690.
24. Heidrich J, Contos L, Hunsaker L, Deck M, Vander D. Inhibition of pancreatic cholesterol esterase reduces cholesterol absorption in the hamster. BMC Pharmacol 2004, 4:5-9. 406500, 15096274.